These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1331236)

  • 1. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
    Abe R; Foo-Phillips M; Granger LG; Kanagawa O
    J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of multiple factors in the clonal deletion of self-reactive T cells.
    Abe R; Kozak CA; Foo-Phillips M; Roberts J; Principato MA
    Cell Immunol; 1993 Oct; 151(2):425-36. PubMed ID: 7691421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
    Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
    Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic expression of two superantigens in the BDF1 mouse.
    Gollob KJ; Palmer E
    J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant induction of T cell tolerance in B cell suppressed mice.
    Gollob KJ; Palmer E
    J Immunol; 1993 May; 150(9):3705-12. PubMed ID: 8473728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E-reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen.
    Abe R; Kanagawa O; Sheard MA; Malissen B; Foo-Phillips M
    J Immunol; 1991 Aug; 147(3):739-49. PubMed ID: 1713604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.
    Dyson PJ; Knight AM; Fairchild S; Simpson E; Tomonari K
    Nature; 1991 Feb; 349(6309):531-2. PubMed ID: 1846950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
    Tucek CL; Desaymard C; Papiernik M
    J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of Mls-like superantigens: analysis of TCR requirements, superantigenic ligands, and signal transduction.
    Hodes RJ; Abe R
    Semin Immunol; 1992 Oct; 4(5):319-27. PubMed ID: 1336682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.